Conservative and functional surgery in the treatment of salivary gland tumours

Abstract

The principle of modern oncological surgery is to conserve the functional organs or tissues as much as possible based on eradication of the tumour. For salivary gland tumours, conservative and functional salivary surgery, including partial sialoadenectomy as well as anatomical and functional preservation of the facial nerve, great auricular nerve, superficial musculo-aponeurotic system (SMAS), and Stensen’s duct, has become increasingly popular. In the present review, we discuss the following aspects of conservative and functional surgery in the treatment of salivary gland tumours: (i) partial superficial parotidectomy (PP) to treat benign parotid gland tumours, (ii) modification of surgical incisions to improve cosmetic results, (iii) modification of the surgical approach to decrease complications, (iv) extracardial dissection to treat benign superficial parotid tumours, (v) partial sialoadenectomy to treat benign submandibular gland tumours, and (vi) ¹²⁵I brachytherapy to preserve facial nerves. The majority of the operated parotid or submandibular glands are preserved, and surgical complications are also decreased. Conservative and functional surgery plays a significant role in maintaining normal salivary gland function and in improving patients’ quality of life during the treatment of salivary gland tumours and thus should be further promoted.

References

[1] Yu, S. F. Oral Histopathology (People’s Medical Publishing House, Beijing, China, 2007).

[2] Gao M, . Salivary gland tumours in a Northern Chinese population: a 50-year retrospective study of 7190 cases. Int. J. Oral Maxillofac. Surg., 2017, 46: 343-349.

[3] Yamashita T, Tomoda K, Kumazawa T. The usefulness of partial parotidectomy for benign parotid gland tumors. A retrospective study of 306 cases. Acta Otolaryngol. Suppl., 1993, 500: 113-116.

[4] McGurk M, Renehan A, Gleave EN, Hancock BD. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas. Br. J. Surg., 1996, 83: 1747-1749.

[5] Roh JL, Park CI. Gland-preserving surgery for pleomorphic adenoma in the submandibular gland. Br. J. Surg., 2008, 95: 1252-1256.

[6] Zhang SS, . Conservation of salivary secretion and facial nerve function in partial superficial parotidectomy. Int. J. Oral Maxillofac. Surg., 2013, 42: 868-873.

[7] Yu G, Ma D. Functional parotid surgery. Chin. J. Clin. Oncol., 2010, 37: 908-910.

[8] Yu GY, Ma DQ, Liu XB, Zhang MY, Zhang Q. Local excision of the parotid gland in the treatment of Warthin’s tumour. Br. J. Oral Maxillofac. Surg., 1998, 36: 186-189.

[9] Stathopoulos P, Igoumenakis D, Smith WP. Partial superficial, superficial, and total parotidectomy in the management of benign parotid gland tumors: a 10-year prospective study of 205 patients. J. Oral Maxillofac. Surg., 2018, 76: 455-459.

[10] Mao C, . Modified parotidectomy. J. Mod. Stomatol., 2002, 16: 62-64.

[11] Wang Y, Guo CB, Peng X, Yu GY. Application of the combined pre- and retro-auricular incision in superficial parotidectomy. J. Peking. Univ. (Health Sci.), 2012, 44: 47-50.

[12] Jo M-G, Lee D-J, Cha W. A modified V-shaped incision combined with superficial musculo-aponeurotic system flap for parotidectomy. Acta Otolaryngol., 2019, 139: 178-183.

[13] Yu GY, . Pre-mental foramen mandibulotomy for resecting tumors of tongue base and parapharyngeal space. Chin. Med. J., 2005, 118: 1803-1807.

[14] Gao M, Chen Y, Gao Y, Peng X, Yu GY. Clinicopathologic characteristics and management of parotid pleomorphic adenomas closely abutting the facial nerve. J. Peking. Univ. (Health Sci.), 2012, 44: 43-46.

[15] McGurk M, Thomas BL, Renehan AG. Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br. J. Cancer, 2003, 89: 1610-1613.

[16] Renehan A, Gleave EN, McGurk M. An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland. Am. J. Surg., 1996, 172: 710-714.

[17] Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J. Prosthet. Dent., 2001, 85: 162-169.

[18] Ge N, . Partial sialoadenectomy for the treatment of benign tumours in the submandibular gland. Int. J. Oral Maxillofac. Surg., 2016, 45: 750-755.

[19] Laskawi R, Ellies M, Arglebe C, Schott A. Surgical management of benign tumors of the submandibular gland: a follow-up study. J. Oral Maxillofac. Surg., 1995, 53: 506-508.

[20] Springborg LK, Moller MN. Submandibular gland excision: long-term clinical outcome in 139 patients operated in a single institution. Eur. Arch. Otorhinolaryngol., 2013, 270: 1441-1446.

[21] Li L, . Anatomy of arteries and veins of submandibular glands. Chin. Med. J., 2007, 120: 1179-1182.

[22] min R, . Gland-preserving surgery can effectively preserve gland function without increased recurrence in treatment of benign submandibular gland tumour. Br. J. Oral Maxillofac. Surg., 2013, 51: 615-619.

[23] Zhang J, . ¹²⁵I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors. Int. J. Oral Maxillofac. Surg., 2008, 37: 515-520.